4.5 Article

Rutin, a Flavonoid and Principal Component of Saussurea Involucrata, Attenuates Physical Fatigue in a Forced Swimming Mouse Model

Journal

INTERNATIONAL JOURNAL OF MEDICAL SCIENCES
Volume 11, Issue 5, Pages 528-537

Publisher

IVYSPRING INT PUBL
DOI: 10.7150/ijms.8220

Keywords

rutin; S. involucrate; physical fatigue

Funding

  1. National Science Council of the Republic of China [101-2320-B-197-001-MY2, 102-2320-B-002-029]

Ask authors/readers for more resources

This study investigated the antifatigue effects of rutin, a flavonoid extracted from the ethyl acetate extract of S. involucrata. Mice were subjected to a weight-loaded forced swim test (WFST) on alternate days for 3 wk. Rutin was administered orally to the mice for 7 days in dosages of 15, 30, and 60 mg/kg body weight, and several biomarkers of physical fatigue were evaluated: swimming time, change in body weight, lipid peroxidation, lactic acid (LA), glycogen, and the activities of the antioxidant enzymes superoxide dismutase (SOD) and glutathione peroxidase (GPx). On Day 7, the rutin-treated mice had a 3-fold longer exhaustive swimming time than the control mice, as well as significantly reduced blood LA concentrations. The 15, 30, and 60 mg/kg body weight rutin-supplemented groups displayed 11.2%, 22.5%, and 37.7% reduced malondialdehyde (MDA) concentrations, respectively, in brain and muscle tissues compared with the control exercised group. Our results indicated that the administration of rutin protected the mice against the depletion of SOD and GPx activities significantly. Following 7 days of rutin treatment, we sacrificed the mice and analyzed their soleus muscle and brain for peroxisome proliferator-activated receptor-a coactivator (PGC-1 alpha) and sirtuin 1 (SIRT1) mRNA expression. We observed that rutin treatment increased PGC-1 alpha and SIRT1 mRNA and protein expression. The changes in these markers of mitochondrial biogenesis were associated with increased maximal endurance capacity. The application of 2D gel electrophoresis to analyze the rutin-responsive protein profiles in the WFST mouse brain further revealed the upregulation of the CBI cannabinoid receptor-interacting protein 1, myelin basic protein, Rho GDP dissociation inhibitor (GDI) alpha, and TPI, indicating that rutin might inhibit anxiety through the upregulation of the expression of anxiety-associated proteins. Western blot analysis of MAPK expression further confirmed the antianxiety effects of rutin. Our study results thus indicate that rutin treatment ameliorates the various impairments associated with physical fatigue.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Gastroenterology & Hepatology

Cryptogenic hepatocellular carcinoma: characteristics, outcome, and prognostic role of albumin-bilirubin (ALBI) grade vs easy ALBI grade

Shu-Yein Ho, Mei-Hsia Yuan, Po-Hong Liu, Chia-Yang Hsu, Yi-Hsiang Huang, Jia- Liao, Chien-Wei Su, Chia-Lin Wang, Ming-Chih Hou, Teh-la Huo

Summary: Patients with cryptogenic HCC have larger tumor burden and advanced cancer stage at disease presentation compared to those with viral HCC. ALBI and EZ-ALBI scores are robust models to evaluate liver functional reserve for these patients independent of treatment modality.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2023)

Article Gastroenterology & Hepatology

Hepatocellular carcinoma risk in patients with chronic hepatitis B receiving tenofovir- vs. entecavir-based regimens: Individual patient data meta-analysis

Won-Mook Choi, Terry Cheuk-Fung Yip, Grace Lai-Hung Wong, W. Ray Kim, Leland J. Yee, Craig Brooks-Rooney, Tristan Curteis, Harriet Cant, Chien-Hung Chen, Chi-Yi Chen, Yi-Hsiang Huang, Young-Joo Jin, Dae Won Jun, Jin-Woo Kim, Neung Hwa Park, Cheng-Yuan Peng, Hyun Phil Shin, Woo Shin, Yao-Hsu Yang, Young-Suk Lim

Summary: This study compared the risk of hepatocellular carcinoma (HCC) in chronic hepatitis B (CHB) patients receiving tenofovir disoproxil fumarate (TDF) versus entecavir (ETV) treatment. The results showed that patients receiving TDF had a significantly lower HCC risk, especially those with HBeAg positivity.

JOURNAL OF HEPATOLOGY (2023)

Article Medicine, General & Internal

Lockdown period during SARS COVID-19 endemic outbreak in Taiwan did not cause an increase of the complications nor mortality of patients received endoscopic retrograde cholangiopancreatography: A single-center retrospective study

Chia-Ju Li, Tien-En Chang, Ming-Chih Hou, Yi-Hsiang Huang, Pei-Chang Lee, Nai-Wen Chang, Yu-Jen Chen, Fa-Yuah Lee

Summary: During the lockdown period from May 16 to July 26, 2021, patients had longer hospital stays and higher biliary tract enzyme levels, indicating more severe disease. However, ERCP could be safely and successfully performed even during the lockdown period without causing an increase in procedure-related complications and mortality.

JOURNAL OF THE CHINESE MEDICAL ASSOCIATION (2023)

Article Medicine, General & Internal

The outcomes and prognostic factors of patients with hepatocellular carcinoma and normal serum alpha fetoprotein levels

Chia-Chu Fu, Cheng-Yi Wei, Chi-Jen Chu, Pei-Chang Lee, Teh-Ia Huo, Yi-Hsiang Huang, Yee Chao, Ming-Chih Hou, Jaw-Ching Wu, Chien-Wei Su

Summary: This study retrospectively enrolled 2198 patients with HCC and normal serum AFP levels. The results showed that liver functional reserve, anti-viral therapy, tumor size, vascular invasion, and treatment modalities were prognostic factors for HCC patients with normal serum AFP levels, while serum AFP levels themselves were not associated with prognosis.

JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2023)

Article Gastroenterology & Hepatology

Hepatic steatosis and metabolic risk factors among patients with chronic hepatitis B: The multicentre, prospective CAP-Asia study

Yong-Wen Leow, Wah-Kheong Chan, George Boon-Bee Goh, Vincent Wai-Sun Wong, Jian Gao Fan, Young Seok Kim, Seung Up Kim, Atsushi Nakajima, Wai-Kay Seto, I-Cheng Lee, Yi-Hsiang Huang, Yoon Jun Kim, Jang Jae Young, Wan Cheng Chow

Summary: We conducted a clinical study on patients with chronic hepatitis B (CHB) to compare the severity, metabolic profile, and cardiovascular disease (CVD) risk of patients with and without hepatic steatosis, as well as patients with non-alcoholic fatty liver disease (NAFLD). The study found that a high proportion (59%) of CHB patients had hepatic steatosis. There was a gradual increase in liver function indicators, liver stiffness measurement, metabolic syndrome prevalence, and CVD risk from CHB patients without hepatic steatosis to CHB patients with hepatic steatosis to NAFLD patients. Therefore, CHB patients with hepatic steatosis should be diagnosed and managed according to their metabolic risk factors for better long-term outcomes.

JOURNAL OF VIRAL HEPATITIS (2023)

Article Gastroenterology & Hepatology

Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study

Thomas Talbot, Antonio D'Alessio, Matthias Pinter, Lorenz Balcar, Bernhard Scheiner, Thomas U. Marron, Tomi Jun, Sirish Dharmapuri, Celina Ang, Anwaar Saeed, Hannah Hildebrand, Mahvish Muzaffar, Claudia A. M. Fulgenzi, Suneetha Amara, Abdul Rafeh Naqash, Anuhya Gampa, Anjana Pillai, Yinghong Wang, Uqba Khan, Pei-Chang Lee, Yi-Hsiang Huang, Bertram Bengsch, Dominik Bettinger, Yehia Mohamed, Ahmed Kaseb, Tiziana Pressiani, Nicola Personeni, Lorenza Rimassa, Naoshi Nishida, Masatoshi Kudo, Arndt Weinmann, Peter R. Galle, Ambreen Muhammed, Alessio Cortellini, Arndt Vogel, David J. Pinato

Summary: Different treatment strategies after the progression of hepatocellular carcinoma (HCC) include continuing immune checkpoint inhibitors (ICIs), switching to tyrosine kinase inhibitors (TKIs), and stopping anticancer therapy. This study found that continuing ICI treatment and sequential treatment of ICI and TKI were effective strategies. However, intrahepatic growth and new vascular invasion were associated with poorer prognosis.

LIVER INTERNATIONAL (2023)

Article Medicine, Research & Experimental

Senomorphic effect of diphenyleneiodonium through AMPK/MFF/DRP1 mediated mitochondrial fission

Keng-Mao Liao, Chih-Jung Chen, Wei-Jia Luo, Chen-Wei Hsu, Sung-Liang Yu, Pan-Chyr Yang, Kang-Yi Su

Summary: With an aging population and the numerous health impacts associated with old age, there is a growing need to find effective anti-aging drugs. In this study, diphenyleneiodonium (DPI) was identified as a potential anti-aging drug that promotes mitochondrial fission. DPI was found to reduce senescence-associated beta-galactosidase positive cells and increase proliferating cells. It also downregulated cell cycle arrest genes and SASP factors. DPI treatment in mice showed reduced senescence markers and improved physical impairments.

BIOMEDICINE & PHARMACOTHERAPY (2023)

Article Psychiatry

All-Cause and Cause-Specific Mortality in Parents After the Death of a Child in Taiwan: A Population-Based Cohort Study

Ying-Yeh Chen, David Gunnell, Chia-Kai Wu, Ya-Hui Hu, Pei-Chen Lee

Summary: By analyzing national registers in Taiwan, we found that parents who experienced the death of a child had an increased risk of mortality. This risk was higher for bereaved mothers than fathers. The cause of the child's death did not affect the risk, but parents whose child died from unexpected causes were at greater risk. Additionally, the risk was higher when the child was older than 1 year at the time of death.

PSYCHOSOMATIC MEDICINE (2023)

Article Multidisciplinary Sciences

Risks of organ failures and deaths associated with young-onset dementia after hospitalizations for motor vehicle crash injuries: a nationwide population-based retrospective cohort study

Chien-Hui Liu, Jiun-Yi Wang, Kun-Chia Chang, Ming-Chung Ko, Pei-Chen Lee, Chih-Ching Liu

Summary: Patients with young-onset dementia (YOD) are at increased risks of adverse outcomes after hospitalization for motor vehicle crash injury (MVCI). This retrospective cohort study found that YOD patients had higher rates of ICU admission, respiratory failure, in-hospital mortality, 30-day mortality, length of hospital stay, and hospital costs compared to MVCI patients without YOD.

SCIENTIFIC REPORTS (2023)

Article Oncology

Comparison of Four Albumin-Based Liver Reserve Models (ALBI/EZ-ALBI/PALBI/PAL) against MELD for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization

Shu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, Yi-Hsiang Huang, Jia- Liao, Chien-Wei Su, Ming-Chih Hou, Teh-Ia Huo

Summary: Liver functional reserve is critical in managing hepatocellular carcinoma (HCC) patients. This study compared four albumin-based liver reserve models (ALBI/EZ-ALBI/PALBI/PAL) versus MELD in HCC patients undergoing transarterial chemoembolization (TACE) and found that all four albumin-based models were better prognostic tools than MELD scores. Among them, PALBI score was the best model for evaluating liver reserve.

CANCERS (2023)

Article Oncology

Outcomes of beta blocker use in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors

Y. Linda Wu, Grace van Hyfte, Umut Ozbek, Marlene Reincke, Anuhya Gampa, Yehia I. Mohamed, Naoshi Nishida, Brooke Wietharn, Suneetha Amara, Pei-Chang Lee, Bernhard Scheiner, Lorenz Balcar, Matthias Pinter, Arndt Vogel, Arndt Weinmann, Anwaar Saeed, Anjana Pillai, Lorenza Rimassa, Abdul Rafeh Naqash, Mahvish Muzaffar, Yi-Hsiang Huang, Ahmed O. Kaseb, Masatoshi Kudo, David J. Pinato, Celina Ang

Summary: Beta blocker use was not associated with overall survival, progression-free survival, or objective response rate in patients with unresectable hepatocellular carcinoma treated with immune checkpoint inhibitors.

FRONTIERS IN ONCOLOGY (2023)

Article Cell Biology

High-fat diet induces C-reactive protein secretion, promoting lung adenocarcinoma via immune microenvironment modulation

Wei-Lun Hsu, Yun-Ting Hsieh, Wei-Ming Chen, Min-Hui Chien, Wei-Jia Luo, Jung-Hsuan Chang, Kevin Devlin, Kang-Yi Su

Summary: High-fat diets can alter the immune microenvironment of lung cancer, promoting tumor growth, and C-reactive protein plays a significant role in this process.

DISEASE MODELS & MECHANISMS (2023)

Article Oncology

Whole exome sequencing and MicroRNA profiling of lung adenocarcinoma identified risk prediction features for tumors at stage I and its substages

Hao Ho, Sung-Liang Yu, Hsuan-Yu Chen, Shin-Sheng Yuan, Kang-Yi Su, Yi-Chiung Hsu, Chung-Ping Hsu, Cheng-Yen Chuang, Ya-Hsuan Chang, Yu-Cheng Li, Chiou-Ling Cheng, Gee-Chen Chang, Pan-Chyr Yang, Ker-Chau Li

Summary: This study identified molecular features associated with relapse-free survival in stage I lung adenocarcinoma patients through genomic analysis. These findings provide additional options for precision management of stage I lung adenocarcinoma patients.

LUNG CANCER (2023)

Article Oncology

Radiologic Patterns Determine the Outcomes of Initial and Subsequent Transarterial Chemoembolization in Intermediate-Stage Hepatocellular Carcinoma

Ya-Wen Hung, I-Cheng Lee, Chen-Ta Chi, Rheun-Chuan Lee, Chien-An Liu, Nai-Chi Chiu, Hsuen-En Hwang, Yee Chao, Ming-Chih Hou, Yi-Hsiang Huang

Summary: This study investigated the influence of radiologic morphology on the outcomes of initial and subsequent transarterial chemoembolization (TACE) for intermediate-stage hepatocellular carcinoma (HCC). The results showed that radiologic morphology was significantly associated with treatment response rate and overall survival. Systemic therapy should be considered for patients with unfavorable radiologic patterns of intermediate-stage HCC after TACE.

LIVER CANCER (2023)

Article Surgery

Risk Stratification for Hepatitis B Virus Reactivation in Kidney Transplant Recipients With Resolved HBV Infection

Hsin-Ju Tsai, Ming-Ju Wu, Cheng-Hsu Chen, Sheng-Shun Yang, Yi-Hsiang Huang, Yan-Zin Chang, Horng-Rong Chang, Teng-Yu Lee

Summary: This hospital-based retrospective cohort study found that the prophylaxis strategy for HBV reactivation in kidney transplant recipients with resolved HBV infection remains unclear. The absence of anti-HBs antibody and the use of high-dose steroids were identified as independent risk factors for HBV reactivation. Therefore, the strategy of HBV antiviral prophylaxis may be defined according to the risk stratification.

TRANSPLANT INTERNATIONAL (2023)

No Data Available